Lucas AE, Smeenk FW, Smeele IJ, van Schayck CP: Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract. 2008, 25 (2): 86-91. 10.1093/fampra/cmn006.
Article
CAS
PubMed
Google Scholar
LindenSmith J, Morrison D, Deveau C, Hernandez P: Overdiagnosis of asthma in the community. Can Respir J. 2004, 11 (2): 111-116.
Article
PubMed
Google Scholar
Luks VP, Vandemheen KL, Aaron SD: Confirmation of asthma in an era of overdiagnosis. Eur Respir J. 2010, 36 (2): 255-260. 10.1183/09031936.00165109.
Article
CAS
PubMed
Google Scholar
Babb TG, Ranasinghe KG, Comeau LA, Semon TL, Schwartz B: Dyspnea on exertion in obese women: association with an increased oxygen cost of breathing. Am J Respir Crit Care Med. 2008, 178 (2): 116-123. 10.1164/rccm.200706-875OC.
Article
PubMed
Google Scholar
Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, et al: General considerations for lung function testing. Eur Respir J. 2005, 26 (1): 153-161. 10.1183/09031936.05.00034505.
Article
CAS
PubMed
Google Scholar
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183/09031936.05.00034805.
Article
CAS
PubMed
Google Scholar
Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, et al: Standardisation of the measurement of lung volumes. Eur Respir J. 2005, 26 (3): 511-522. 10.1183/09031936.05.00035005.
Article
CAS
PubMed
Google Scholar
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al: Interpretative strategies for lung function tests. Eur Respir J. 2005, 26 (5): 948-968. 10.1183/09031936.05.00035205.
Article
CAS
PubMed
Google Scholar
Aaron SD, Vandemheen KL, Boulet LP, McIvor RA, Fitzgerald JM, Hernandez P, Lemiere C, Sharma S, Field SK, Alvarez GG, et al: Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008, 179 (11): 1121-1131. 10.1503/cmaj.081332.
Article
PubMed
PubMed Central
Google Scholar
Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ: The Total Work of Breathing in Normal and Obese Men. J Clin Invest. 1964, 43: 728-739. 10.1172/JCI104957.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang ML, McCabe L, Petsonk EL, Hankinson JL, Banks DE: Weight gain and longitudinal changes in lung function in steel workers. Chest. 1997, 111 (6): 1526-1532. 10.1378/chest.111.6.1526.
Article
CAS
PubMed
Google Scholar
Bottai M, Pistelli F, Di Pede F, Carrozzi L, Baldacci S, Matteelli G, Scognamiglio A, Viegi G: Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J. 2002, 20 (3): 665-673. 10.1183/09031936.02.01282001.
Article
CAS
PubMed
Google Scholar
Beuther DA, Sutherland ER: Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007, 175 (7): 661-666. 10.1164/rccm.200611-1717OC.
Article
PubMed
PubMed Central
Google Scholar
Vozoris NT, Stanbrook MB: Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011, 105 (3): 477-484. 10.1016/j.rmed.2010.08.011.
Article
PubMed
Google Scholar
McClean KM, Kee F, Young IS, Elborn JS: Obesity and the lung: 1. Epidemiology. Thorax. 2008, 63 (7): 649-654. 10.1136/thx.2007.086801.
Article
CAS
PubMed
Google Scholar
Slain D, Kincaid SE, Dunsworth TS: Discrepancies between home medications listed at hospital admission and reported medical conditions. Am J Geriatr Pharmacother. 2008, 6 (3): 161-166. 10.1016/j.amjopharm.2008.07.001.
Article
PubMed
Google Scholar
Pham CQ, Regal RE, Bostwick TR, Knauf KS: Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006, 40 (7–8): 1261-1266.
Article
CAS
PubMed
Google Scholar
Byrnes PD: Why haven't I changed that? Therapeutic inertia in general practice. Aust Fam Physician. 2011, 40 (1–2): 24-28.
PubMed
Google Scholar
Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H: The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991, 324 (6): 377-384. 10.1056/NEJM199102073240605.
Article
CAS
PubMed
Google Scholar
Joint Commision: Using medication reconsiliation to prevent errors. http://www.jointcommission.org/assets/1/18/SEA_35.pdf,
Schiff GD, Kim S, Abrams R, et al: Diagnosing diagnosis errors: Lessons from a multi-institutional collaborative project. Advances in Patient Safety: From Research to Implementation. http://www.ahrq.gov/qual/advances/ Accessed April 23, 2012
Sin DD, Jones RL, Man SF: Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002, 162 (13): 1477-1481. 10.1001/archinte.162.13.1477.
Article
PubMed
Google Scholar
Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM: The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006, 129 (1): 15-26. 10.1378/chest.129.1.15.
Article
CAS
PubMed
Google Scholar
Singh S, Loke YK, Furberg CD: Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008, 300 (12): 1439-1450. 10.1001/jama.300.12.1439.
Article
CAS
PubMed
Google Scholar
UpToDate. http://www.uptodate.com/contents/major-side-effects-of-inhaled-glucocorticoids,
Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010, 303 (3): 235-241. 10.1001/jama.2009.2014.
Article
CAS
PubMed
Google Scholar
United States Census Bureau: http://www.census.gov/compendia/statab/cats/population.html. Accessed April 20, 2012
Puig A, McElligott S, Bergquist H, Doshi JA: Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother. 2010, 8 (6): 571-582. 10.1016/S1543-5946(10)80006-6.
Article
PubMed
Google Scholar
Halpern R, Baker CL, Su J, Woodruff KB, Paulose-Ram R, Porter V, Shah H: Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease. Patient Preference Adherence. 2011, 5: 375-388.
PubMed
PubMed Central
Google Scholar
Chhabra SK: Forced vital capacity, slow vital capacity, or inspiratory vital capacity: which is the best measure of vital capacity?. J Asthma. 1998, 35 (4): 361-365. 10.3109/02770909809075669.
Article
CAS
PubMed
Google Scholar
Sabater JR, Lee TA, Abraham WM: Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep. Chest. 2005, 128 (5): 3743-3749. 10.1378/chest.128.5.3743.
Article
CAS
PubMed
Google Scholar